Author: <span>Walter Pacheco</span>
Cancer Research UK, mesothelioma care, Mesothelioma News, mesothelioma nurses, mesothelioma palliative treatment, Mesothelioma Research, Mesothelioma UK, National Lung Cancer Forum for Nurses, palliative care for mesothelioma, Pat Stone Meso Support, Pat Stone mesothelioma

New UK Grant: Turning Nurses into Mesothelioma Researchers

 

A pair of U.K. charities is funding a grant that places the future of mesothelioma care and research in the hands of nurses. Mesothelioma UK, a charitable trust and resource center based at Glenfield Hospital in Leicester, teamed with asbestos-related disease awareness organization Pat Stone Meso Support to establish a grant worth 25,000 pounds ($32,000)….

The post New UK Grant: Turning Nurses into Mesothelioma Researchers appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

chemotherapy clinical trial, chemotherapy for mesothelioma, doctor shirish gadgeel, first line treatment for mesothelioma, Human Investigation Committee at Wayne State, mesothelioma diagnosis, Mesothelioma News, peritoneal mesothelioma, treatment for mesothelioma, wayne state university

Study Shows Impact of Chemotherapy on Mesothelioma

 

A U.S.-based study confirms what oncology experts have suggested for years — chemotherapy treatment prolongs life expectancy for malignant mesothelioma patients. Wayne State University School of Medicine researchers linked data from the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) database with Medicare claims data. The study took into account patient characteristics such as…

The post Study Shows Impact of Chemotherapy on Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos ban, Asbestos regulations, banning asbestos in the u.s., dangerous chemicals, Environmental Protection Agency, epa asbestos regulations, Frank R. Lautenberg Chemical Safety for the 21st Century Act, Mesothelioma News, Rebecca Meuninck, top 10 dangerous chemicals

EPA Includes Asbestos in Top 10 Dangerous Chemicals

 

Asbestos, a mineral linked to various deadly health conditions and cancer such as mesothelioma, may finally get the scrutiny it needs so regulators can ban the toxic substance in the U.S. The lethal mineral is now among the top 10 substances the U.S. Environmental Protection Agency must review in accordance to the newly reformed Toxic…

The post EPA Includes Asbestos in Top 10 Dangerous Chemicals appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure, clare cameron, doctor robert cameron, International Symposium on Malignant Pleural Mesothelioma, mesenchymal stem cells, mesothelioma cancer research, Mesothelioma News, Mesothelioma Research, mesothelioma tissue bank, national mesothelioma virtual bank, Pacific Heart Lung and Blood Institute, pacific mesothelioma center, stem cells research for mesothelioma, UCLA cancer treatment

Future of Mesothelioma Research Lies in Growing Tissue Bank

 

A year after establishing its own tissue bank, the Pacific Heart, Lung & Blood Institute (PHLBI) in California is looking for additional funding and tissue samples to continue research of pleural mesothelioma and other diseases. Currently, there isn’t an international bank for the collection of tissue. “We eventually want to be in a position where…

The post Future of Mesothelioma Research Lies in Growing Tissue Bank appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure, clare cameron, doctor robert cameron, International Symposium on Malignant Pleural Mesothelioma, mesenchymal stem cells, mesothelioma cancer research, Mesothelioma News, Mesothelioma Research, mesothelioma tissue bank, national mesothelioma virtual bank, Pacific Heart Lung and Blood Institute, pacific mesothelioma center, stem cells research for mesothelioma, UCLA cancer treatment

Future of Mesothelioma Research Lies in Growing Tissue Bank

 

A year after establishing its own tissue bank, the Pacific Heart, Lung & Blood Institute (PHLBI) in California is looking for additional funding and tissue samples to continue research of pleural mesothelioma and other diseases. Currently, there isn’t an international bank for the collection of tissue. “We eventually want to be in a position where…

The post Future of Mesothelioma Research Lies in Growing Tissue Bank appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure in california, asbestos related cancer, california supreme court asbestos ruling, mesothelioma, mesothelioma attorney, mesothelioma in california, Mesothelioma lawyer, mesothelioma lawyer california, Mesothelioma News, secondhand asbestos exposure, takehome asbestos

New Ruling Favors Secondhand Asbestos Exposure Victims

 

The California Supreme Court ruled last week that companies remain liable for secondhand asbestos exposure if the toxic material sickens a family member. The ruling may provide a clearer path for plaintiffs outside the workplace to bring legal action against asbestos manufacturers. It will help those harmed by asbestos that was inadvertently brought home by…

The post New Ruling Favors Secondhand Asbestos Exposure Victims appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

75 years after pearl harbor, Mesothelioma News, pearl harbor 75th anniversary, pearl harbor attack, pearl harbor attack anniversary, veterans exposed to asbestos

Pearl Harbor: 75th Anniversary & Future Asbestos Dangers for Veterans

 

Seventy-five years later, Dec. 7, 1941, still lives in infamy. Wednesday marks the 75th anniversary of the attack on Pearl Harbor. The surprise Japanese military strike killed 2,403 Americans and wounded another 1,178, devastating the U.S. naval base and dragging the nation into World War II. But the death toll continued to rise decades after…

The post Pearl Harbor: 75th Anniversary & Future Asbestos Dangers for Veterans appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

cryoablation for cancer, cryoablation for mesothelioma, cryosurgery for mesothelioma, cryotherapy for mesothelioma, freezing cancer tumors, Mesothelioma News, Mesothelioma treatment

Cryoablation Successfully Treats Recurrent Mesothelioma

 

Radiologists at the UCLA Medical Center are successfully killing tumor cells with extreme cold, also known as cryoablation, in patients with recurrent pleural mesothelioma. An outpatient procedure with few complications, cryoablation freezes the localized tumors with argon gas or liquid nitrogen, allowing patients to fight the almost-inevitable cancer recurrence after surgery. Dr. Fereidoun Abtin, a…

The post Cryoablation Successfully Treats Recurrent Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

doctor joseph friedberg, late stage mesothelioma, Mesothelioma News, stage 3 mesothelioma, stage 4 mesothelioma, stage III mesothelioma, stage IV mesothelioma, treatment for late stage mesothelioma, treatment for pleural mesothelioma

Extending Late-Stage Mesothelioma Survival with Light Energy

 

Thoracic surgeon Dr. Joseph Friedberg and his colleagues identified a subset of patients with pleural mesothelioma who achieved a median overall survival of 7.3 years — an impressive survival compared to the usual one-year prognosis. The findings, which were published recently in The Annals of Thoracic Surgery, stemmed from a retrospective study that detailed significant…

The post Extending Late-Stage Mesothelioma Survival with Light Energy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

chemotherapy for mesothelioma, growth of mesothelioma tumors, how do mesothelioma tumors grow, mesothelioma clinical trials, Mesothelioma News, Mesothelioma Research, Mesothelioma treatment, mesothelioma tumor growth, mesothelioma tumors

Study Uncovers Strange Growth of Mesothelioma Tumors

 

A new analysis on how asbestos-related tumors grow may lead to more effective research and treatments of malignant mesothelioma. Researchers at Australia’s Flinders University found malignant mesothelioma tumors demonstrate vasculogenic (vascular) mimicry — the process in which tumors make their own blood vessels. Tumors promote their own growth by growing blood vessels that reach into…

The post Study Uncovers Strange Growth of Mesothelioma Tumors appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

cancer tumor growth, chemotherapy for mesothelioma, growth of mesothelioma tumors, how do mesothelioma tumors grow, mesothelioma clinical trials, Mesothelioma News, Mesothelioma Research, Mesothelioma treatment, mesothelioma tumor growth, mesothelioma tumors

Study Uncovers Strange Growth of Mesothelioma Tumors

 

A new analysis on how asbestos-related tumors grow may lead to more effective research and treatments of malignant mesothelioma. Researchers at Australia’s Flinders University found malignant mesothelioma tumors demonstrate vasculogenic (vascular) mimicry — the process in which tumors make their own blood vessels. Tumors promote their own growth by growing blood vessels that reach into…

The post Study Uncovers Strange Growth of Mesothelioma Tumors appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure in nevada, asbestos exposure in women, environmental asbestos, environmental exposure to asbestos, mesothelioma deaths from asbestos, mesothelioma diagnosis, mesothelioma in women, Mesothelioma News

Environmental Asbestos Raises Mesothelioma Among Women

 

For decades, mesothelioma has predominately affected white men older than 60 years of age. This is largely because of the rare cancer’s connection to occupational asbestos exposure and its long latency period of 20 to 50 years. But as worldwide use of asbestos continues to decline and more industrialized countries continue to ban the toxic…

The post Environmental Asbestos Raises Mesothelioma Among Women appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos in talcum powder, mesothelioma cancer from talcum powder, mesothelioma from talcum powder, Mesothelioma News, talcum powder cancer, talcum powder cancer verdict, talcum powder lawsuit, talcum powder mesothelioma lawsuit

Record $18M Verdict in Mesothelioma-Talcum Powder Lawsuit

 

The recent record-setting $18 million verdict out of California rekindled the hotly debated link between talcum powder and mesothelioma cancer. A Los Angeles Superior Court jury awarded Philip Depoian the multimillion-dollar verdict against talc supplier Whittaker, Clark & Daniels. Depoian claimed the company’s asbestos-tainted talcum powder products used at the barbershop where his father worked…

The post Record $18M Verdict in Mesothelioma-Talcum Powder Lawsuit appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

American Society of Clinical Oncology, Betty Ferrell, early palliative care, Mesothelioma News, Mesothelioma treatment, palliative care for cancer, palliative care for mesothelioma, treatment after early mesothelioma diagnosis

Early Palliative Care Improves Mesothelioma Prognosis

 

Mesothelioma cancer patients can live longer and better lives if they begin palliative care sooner, according to a multidisciplinary panel of experts convened by the American Society of Clinical Oncology (ASCO). The panel recommended that palliative care options should be explored almost immediately after diagnosis of mesothelioma, a rare and aggressive cancer with no definitive…

The post Early Palliative Care Improves Mesothelioma Prognosis appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Atezolizumab, bladder cancer drug for mesothelioma, immunotherapy for mesothelioma, keytruda for mesothelioma, Mesothelioma News, opdivo for mesothelioma, Tecentriq

Tecentriq Raises Hope of New Mesothelioma Clinical Trial

 

The FDA recently approved immunotherapy drug Tecentriq (atezolizumab) for certain bladder and non-small cell lung cancers, raising hopes for a mesothelioma-specific clinical trial in 2017. Tecentriq, a product of Genentech Oncology, is following the path of Keytruda (pembrolizumab) and Opdivo (nivolumab) as drugs that target a specific protein blocking a body’s immune system from attacking…

The post Tecentriq Raises Hope of New Mesothelioma Clinical Trial appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.